|
|
Volumn 13, Issue SUPPL. 1, 2002, Pages 96-97
|
|
Current clinical trials for the treatment of adult advanced-stage Hodgkin's disease: GELA experiences
a
|
|
Author keywords
Advanced stages; High dose therapy; Hodgkin's disease
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARMUSTINE;
CHLORMETHINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
MELPHALAN;
MITOGUAZONE;
NAVELBINE;
PREDNISONE;
PROCARBAZINE;
VINBLASTINE;
VINCRISTINE;
ADOLESCENT;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CANCER RECURRENCE;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG RESPONSE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HODGKIN DISEASE;
HUMAN;
MAJOR CLINICAL STUDY;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
SALVAGE THERAPY;
STANDARD;
TREATMENT FAILURE;
TREATMENT OUTCOME;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
RADIATION DOSE;
REVIEW;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HODGKIN DISEASE;
HUMANS;
MIDDLE AGED;
RADIOTHERAPY DOSAGE;
SALVAGE THERAPY;
|
|
EID: 0036050679
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/13.S1.96 Document Type: Article |
|
Times cited : (4)
|
|
References (3)
|
